Table 7.

Correlation Analysis of TAP and CA199 in the Patients with Their Tumor Stage

Dependent Variable	Stage		Mean Difference	Standard Error	Sig.	95% Confidence Interval
						Lower Bound	Upper Bound
TAP	I	II	−2.98218	19.25258	0.877	−41.2251	35.2607
		III	−17.58333	14.39625	0.225	−46.1797	11.0130
		IV	−29.31333	20.86214	0.163	−70.7534	12.1267
	II	I	2.98218	19.25258	0.877	−35.2607	41.2251
		III	−14.60115	16.34124	0.374	−47.0610	17.8587
		IV	−26.33115	22.24889	0.240	−70.5258	17.8635
	III	I	17.58333	14.39625	0.225	−11.0130	46.1797
		II	14.60115	16.34124	0.374	−17.8587	47.0610
		IV	−11.73000	18.20997	0.521	−47.9019	24.4419
	IV	I	29.31333	20.86214	0.163	−12.1267	70.7534
		II	26.3115	22.24889	0.240	−17.8635	70.5258
		III	11.73000	18.20997	0.521	−24.4419	47.9019
CA199	I	II	0.27829	90.95534	0.998	−180.3933	180.9499
		III	−70.26389	68.01245	0.304	−205.3623	64.8345
		IV	−427.24856	98.55940	0.000	−623.0247	−231.4724
	II	I	−0.27829	90.95534	0.998	−180.9499	180.3933
		III	−70.54218	77.20121	0.363	−223.8929	82.8085
		IV	−427.52685	105.11084	0.000	−636.3166	−218.7371
	III	I	70.26389	68.01245	0.304	−64.8345	205.3623
		II	70.54218	77.20121	0.363	−82.8085	223.8929
		IV	−356.98467	86.02969	0.000	−527.8721	−186.0972
	IV	I	427.24856	98.55940	0.000	231.4724	623.0247
		II	427.52685	105.11084	0.000	218.7371	636.3166
		III	356.98476	86.02969	0.000	186.0972	527.8721